Title:

Pharmion Corp (M&A Insight Analysis)

Price:$450.00
Publication Date:Feb 25, 2008
Company:Pharmion Corp
Report Type:M&A Insight Analysis
Brief Excerpt:...PHRM is yet another example that M&A activ ism remains very much alive despite last summer s credit crunch. SAC Capital has i ndicated the $## offer is insufficient and proposed that either the merger considerati on be increased or PHRM should postpone the special meeting until shareholders have the oppor tunity to assess the results of an efficacy study on Dacogen, a competitor drug to Vidaza. Most industry analysts believe that th e proposed combination would make sound strategic sense given product overlap and expe cted synergies. As a biotech company with just two key commercial products, PHRM bears significant concentration risk, and a merger with CELG would diversify the comp any s portfolio of commercial products. ...
Word Count:13941
Length:33 Pages
Ticker:PHRM
Related Report(s):
  • Pharmion Corp (Corporate Governance Quotient (CGQ)): $250.00
    ...Only one inside director and no affiliated outsiders serve on the board The nominating committee is comprised solely of independent outside directors The compensation committee is comprised solely of independent outside directors The company has a committee that oversees governance issues and the committee met in the past year There are between six and eight directors serving on the board The CEO serves on the boards of two or fewer other companies No former CEO of the company serves on the board Chairman and CEO are separated and Chairman is an independent outsider The company has governance guidelines that have been publicly disclosed on company website The performance of the board is reviewed regularly Outside directors meet without the CEO present and the number of meetings of the outside directors is specified A board approved CEO succession plan is in place Board members have express authority to retain outside advisors All directors attended at...
Format:Adobe Acrobat Adobe Acrobat
Free Sample: Click Here to Download

Enter the keyword(s) which you would like to search for within this document and click "Search"

 
Purchase Report
Price: $450.00

Institutional Shareholder Services

Institutional Shareholder Services (ISS) is the leading provider of corporate governance research and analysis. The ISS Corporate Governance Quotient (CGQ) is a database and ranking system designed specifically to evaluate the quality of a company's corporate governance and board of directors. CGQ ratings are available on more than 8,500 companies worldwide. ISS' M&A Insight (M&A Insight Analysis and M&A Insight Note) is a unique offering that delivers ongoing deal notes that keep users abreast of key issues as the deal or contest evolves.

  about us contact us public company index private company index pcan widget your privacy rights terms & conditions